- Presentations
- 3
- Markets
- 1
Caplyta is a brand of Lumateperone marketed by Intra-Cellular Therapies, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Lumateperone
- Brand owner
- Intra-Cellular Therapies
- Registered in
- United States
- Strengths and forms
- 10.5 mg capsule, 21 mg capsule, 42 mg capsule
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Caplyta 10.5 mg capsuleOral | Intra-Cellular Therapies | US FDA | Available on request |
| Caplyta 21 mg capsuleOral | Intra-Cellular Therapies | US FDA | Available on request |
| Caplyta 42 mg capsuleOral | Intra-Cellular Therapies | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Caplyta
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.